论文信息 - DREAM3R: Durvalumab with chemotherapy as first-line treatment in advanced pleural mesothelioma—A phase 3 randomized trial. - 字舞流文

DREAM3R: Durvalumab with chemotherapy as first-line treatment in advanced pleural mesothelioma—A phase 3 randomized trial.

M. Stockler | M. Zauderer | N. Pavlakis | K. O'Byrne | S. Ramalingam | A. Tsao | V. Anagnostou | H. Kindler | Zhuoxin Sun | P. Forde | J. Brahmer | B. Hughes | A. Nowak | W. Lesterhuis | Chris Brown | P. Kok | S. Yip | Alistair M. Cook